drugset
drugset / Trial / NCT00485693

Dose-Ranging Study for Prolonged Postoperative Analgesia in Subject Undergoing Total Knee Arthroplasty

NCT00485693 ↗

Phase 2 Completed 138 enrolled Pacira Pharmaceuticals, Inc
RandomizedParallel-groupDouble-blindTreatment

Summary

Dose-ranging study for prolonged postoperative analgesia in subjects undergoing total knee arthroplasty

Timeline

Start
2007-06
Primary completion
2009-08
Completion
2009-08

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 150 mg Other
Subject SKY0402 Unknown 600 mg Other

Indications

No indication recorded.